The ACHN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ACHN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ACHN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ACHN Detailed Price Forecast - CNN Money||View ACHN Detailed Summary - Google Finance|
|View ACHN Detailed Summary - Yahoo! Finance||View ACHN Stock Research & Analysis - Zacks.com|
|View ACHN Trends & Analysis - Trade-Ideas||View ACHN Major Holders - Barrons|
|View ACHN Call Transcripts - NASDAQ||View ACHN Breaking News & Analysis - Seeking Alpha|
|View ACHN Annual Report - CompanySpotlight.com||View ACHN OTC Short Report - OTCShortReport.com|
|View ACHN Fundamentals - TradeKing||View ACHN SEC Filings - Bar Chart|
|View Historical Prices for ACHN - The WSJ||View Performance/Total Return for ACHN - Morningstar|
|View the Analyst Estimates for ACHN - MarketWatch||View the Earnings History for ACHN - CNBC|
|View the ACHN Earnings - StockMarketWatch||View ACHN Buy or Sell Recommendations - MacroAxis|
|View the ACHN Bullish Patterns - American Bulls||View ACHN Short Pain Metrics - ShortPainBot.com|
|View ACHN Stock Mentions - StockTwits||View ACHN Stock Mentions - PennyStockTweets|
|View ACHN Stock Mentions - Twitter||View ACHN Investment Forum News - Investor Hub|
|View ACHN Stock Mentions - Yahoo! Message Board||View ACHN Stock Mentions - Seeking Alpha|
|View Insider Transactions for ACHN - SECform4.com||View Insider Transactions for ACHN - Insider Cow|
|View ACHN Major Holdings Summary - CNBC||View Insider Disclosure for ACHN - OTC Markets|
|View Insider Transactions for ACHN - Yahoo! Finance||View Institutional Holdings for ACHN - NASDAQ|
|View ACHN Stock Insight & Charts - FinViz.com||View ACHN Investment Charts - StockCharts.com|
|View ACHN Stock Overview & Charts - BarChart||View ACHN User Generated Charts - Trading View|
Why Is Achillion (ACHN) Up 25.6% Since Last Earnings Report?
Posted on Saturday April 06, 2019
Achillion (ACHN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Achillion Meets Enrollment Target in Kidney Disease Studies
Posted on Thursday April 04, 2019
Achillion (ACHN) achieves enrollment target in two mid-stage studies evaluating its lead candidate, ACH-4471 in C3G, a devastating disease affecting the kidney.
Why Achillion Pharmaceuticals Stock Is Jumping Today
Posted on Wednesday April 03, 2019
Reaching a key clinical study milestone provided a nice boost to the biotech stock.
Achillion Announces Enrollment Milestone in Phase 2 Trials for C3 Glomerulopathy
Posted on Wednesday April 03, 2019
Achillion Pharmaceuticals, Inc. (ACHN), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients and families affected by complement-mediated diseases, today announced that it achieved threshold enrollment in the Phase 2 trials of ACH-4471 for patients with C3 glomerulopathy (C3G), a devastating disease affecting the kidney for which there is no approved therapy. ACH-4471 will be evaluated in the six-month blinded, placebo-controlled trial (11 patients) and the 12-month open-label trial (12 patients). “Enrolling our ACH-4471 Phase 2 trials is an important milestone for Achillion, and we would like to thank all of the patients, families, investigators and participating clinical trial sites for their outstanding contributions,” said Joe Truitt, President and Chief Executive Officer at Achillion.